The anti-melanogenic effects of rifampicin were assessed in B16F10 melanoma cells, showing no cytotoxicity at concentrations up to 40 μM and a significant reduction in intracellular tyrosinase activity and melanin content. The gene discussed is TYR; the disease is melanoma.